Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18–40 years old: a possible HIV indicator condition

Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18–40 years old: a possible HIV indicator condition

Bibliographic Details
Main Authors:	Bibas Michele, Pittalis Silvia, Orchi Nicoletta, De Carli Gabriella, Agrati Chiara, Girardi Enrico, Antinori Andrea, Puro Vincenzo, Ippolito Giuseppe
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-05-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-021-00489-1

Similar Items

Publisher Correction: Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18–40 years old: a possible HIV indicator condition
by: Michele Bibas, et al.
Published: (2021-06-01)

Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
by: Li Pang, et al.
Published: (2021-02-01)

Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
by: Oliver C. Lomas, et al.
Published: (2020-06-01)

Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners
by: Charlene M. McShane, et al.
Published: (2019-05-01)

Sarcoidosis and Monoclonal Gammopathy of Undetermined Significance (MGUS): A True Association or Just a Coincidence?
by: Mohamed Hassanein, et al.
Published: (2018-01-01)

Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome
by: Tanjung A. Sumekar, et al.
Published: (2011-01-01)

The “Undetermined Significance” of <sup>18</sup>F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
by: Giorgio Treglia, et al.
Published: (2021-08-01)

Monoclonal Gammopathy of Undetermined Significance
by: Ronald S. Go, MD, et al.
Published: (2017-09-01)

Immunoglobulin abnormalities and monoclonal gammopathy of undetermined significance in uninfected and HIV-infected men
by: Kyle Robert, et al.
Published: (2010-10-01)

Progression from Monoclonal gammopathy of undetermined significance of the immunoglobulin M class (IgM-MGUS) to Waldenstrom Macroglobulinemia is associated with an alteration in lipid metabolism
by: Shahrzad Jalali, et al.
Published: (2021-05-01)

Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
by: Nabeel Aslam, MD, et al.
Published: (2021-08-01)

Monoclonal Gammopathy of Undetermined Significance and Neutrophilic Dermatosis
by: Buthaina Al-Musalhi, et al.
Published: (2016-09-01)

Monoclonal gammopathy of undetermined significance-associated scleromyxoedema
by: Kalgi D Baxi, et al.
Published: (2019-01-01)

Unawareness of HCV serostatus among persons newly diagnosed with HIV
by: Paola Scognamiglio, et al.
Published: (2019-09-01)

Penile Tuberculosis Associated with Monoclonal Gammopathy of Undetermined Significance
by: Wilfred C.H. Wu, et al.
Published: (2006-01-01)

The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients
by: Marie-France Gagnon, MD, et al.
Published: (2019-10-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

The Role of a Monoclonal Gammopathy of Undetermined Significance Diagnosis in Healthcare Utilization
by: Castaneda-Avila, Maira A.
Published: (2021)

Autoimmune retinopathy associated with monoclonal gammopathy of undetermined significance: a case report
by: Emily A. Eton, et al.
Published: (2020-04-01)

IgA Monoclonal Gammopathy of Undetermined Significance and Complication of Streptococcus mitis Bacteremia
by: Jennifer Paterno, et al.
Published: (2020-01-01)

Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019-06-01)

Sneddon-Wilkinson Disease and Monoclonal Gammopathy of Undetermined Significance in the Elderly: Case Report
by: Gabriele Ceccarelli, et al.
Published: (2019-07-01)

Characterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome.
by: Francisca Barceló, et al.
Published: (2015-01-01)

Data quality of the monoclonal gammopathy of undetermined significance diagnosis in a hospital registry
by: Gregersen H, et al.
Published: (2013-08-01)

Noninfectious mixed cryoglobulinaemic glomerulonephritis and monoclonal gammopathy of undetermined significance: a coincidental association?
by: Adam L. Flavell, et al.
Published: (2020-07-01)

Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma
by: Alisse Hannaford BS, et al.
Published: (2017-04-01)

Living kidney donor with monoclonal gammopathy of undetermined significance: Is it a contraindication for kidney donation?
by: Vinay Rathore, et al.
Published: (2019-01-01)

Distinct Nuclear Organization of Telomeres and Centromeres in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
by: Pak Lok Ivan Yu, et al.
Published: (2019-07-01)

Intracytoplasmic inclusions in plasma cells: A diagnostic adjunct in monoclonal gammopathy of undetermined significance
by: Smeeta Gajendra, et al.
Published: (2017-01-01)

Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report
by: Elizabeth Sarah Mayne, et al.
Published: (2018-11-01)

Non-secretory immunoglobulin E myeloma associated with immunoglobulin G monoclonal gammopathy of undetermined significance
by: Masako Yasuyama, et al.
Published: (2012-07-01)

Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma
by: Sarah eTete, et al.
Published: (2014-06-01)

Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma
by: Michael H. Tomasson, et al.
Published: (2018-11-01)

Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study
by: Nicola Hornung, et al.
Published: (2021-09-01)

Gamma gap thresholds and HIV, hepatitis C, and monoclonal gammopathy.
by: Gigi Y Liu, et al.
Published: (2020-01-01)

PARAPROTEINEMIC POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: СLINICAL CASE DESCRIPTION AND LITERATURE REVIEW
by: A. A. Yakovlev, et al.
Published: (2017-09-01)

Advances in the understanding of IgM monoclonal gammopathy of undetermined significance [version 1; referees: 2 approved]
by: Jonas Paludo, et al.
Published: (2017-12-01)

MALDI-TOF analysis of blood serum proteome can predict the presence of monoclonal gammopathy of undetermined significance.
by: Francisca Barceló, et al.
Published: (2018-01-01)

Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
by: Daniela Damasceno, et al.
Published: (2021-03-01)